PAVmed Inc
NASDAQ:PAVM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PAVmed Inc
NASDAQ:PAVM
|
US |
|
A
|
Addus Homecare Corp
XBER:A41
|
US |
|
I
|
IHI Corp
OTC:IHICF
|
JP |
|
Basf Se
MIL:1BAS
|
DE |
|
Smith & Nephew PLC
NYSE:SNN
|
UK |
|
Comer Industries SpA
MIL:COM
|
IT |
|
P
|
Primoris Services Corp
F:1PM
|
US |
|
Fletcher Building Ltd
F:FLQ
|
NZ |
|
W
|
Walmart Inc
SGO:WMT
|
US |
|
Fresenius SE & Co KGaA
MIL:FRE
|
DE |
|
T
|
TE Connectivity Ltd
SWB:9TC
|
CH |
|
S
|
Societe Generale SA
XETRA:SGE
|
FR |
|
B
|
Barrick Gold Corp
XBER:ABR
|
CA |
|
H
|
Huntington Bancshares Inc
XMUN:HU3
|
US |
|
A
|
AMN Healthcare Services Inc
XMUN:HCQ
|
US |
|
F
|
Fresenius Medical Care AG & Co KGaA
F:FME
|
DE |
Wall St Price Targets
PAVM Price Targets Summary
PAVmed Inc
According to Wall Street analysts, the average 1-year price target for
PAVM is 41.31 USD with a low forecast of 16.16 USD and a high forecast of 68.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PAVM's stock price target?
Price Target
41.31
USD
According to Wall Street analysts, the average 1-year price target for
PAVM is 41.31 USD with a low forecast of 16.16 USD and a high forecast of 68.25 USD.
What is the Revenue forecast for PAVmed Inc?
Projected CAGR
206%
The compound annual growth rate for Revenue over the next 2 years is 206%.